Recent studies showing correlations of umbilical cord serum IGF1 levels with both cord stem cell levels and birth weight [30, 31] support the notion that increased fetal growth may increase cancer risk by either increasing pre-leukemic stem cell populations targeted for initiation, or promoting growth or survival of an initiated leukemic stem cell. This evidence concerns the gene IGF1 and cancer.